NSAIDs in sciatica (NIS): study protocol for an investigator-initiated multicentre, randomized placebo-controlled trial of naproxen in patients with sciatica

Lars Grøvle, Eivind Hasvik, Rene Holst, Anne Julsrud Haugen, Lars Grøvle, Eivind Hasvik, Rene Holst, Anne Julsrud Haugen

Abstract

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to treat sciatica, despite insufficient evidence from placebo-controlled trials. NSAIDs may cause serious side effects; hence, there is a strong need to clarify their potential beneficial effects in patients with sciatica.

Methods: This is a multicentre, randomized, placebo-controlled, parallel-group superiority trial. Participants will be recruited among sciatica patients referred to outpatient clinics at hospitals in Norway who have radiating pain below the knee with a severity score of ≥ 4 on a 0-10 numeric rating scale and clinical signs of nerve root or spinal nerve involvement. The intervention consists of oral naproxen 500 mg or placebo twice daily for 10 days. Participants will report the outcomes and adverse events daily using an electronic case report form. The primary endpoint is change in leg pain intensity from baseline to day 10 based on daily observations. The secondary outcomes are back pain intensity, disability, sciatica symptom severity, rescue medication (paracetamol) consumption, opioid use, ability to work or study, 30% and 50% improvement in leg pain, and global perceived change of sciatica/back problem. The outcomes will be analysed using mixed effects models for repeated measurements. The total duration of follow-up is 12 (± 2) days.

Discussion: This trial aims to evaluate the benefits of naproxen, a non-selective NSAID, in patients with sciatica. No important differences in efficacy have been demonstrated between different NSAIDs in the management of musculoskeletal disorders; hence, the results of this trial will likely be applicable to other NSAIDs.

Trial registration: ClinicalTrials.gov NCT03347929 . Registered on November 20, 2017.

Keywords: Disc herniation; Low back-related leg pain; Lumbosacral radicular pain; NSAID; Naproxen; Nonsteroidal anti-inflammatory drug; Randomized controlled trial; Sciatica.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. Koes BW, Van Tulder M, Peul WC. Diagnosis and treatment of sciatica. BMJ. 2007;334(7607):1313–1317. doi: 10.1136/.
    1. Rydevik BL, Pedowitz RA, Hargens AR, Swenson MR, Myers RR, Garfin SR. Effects of acute, graded compression on spinal nerve root function and structure. An experimental study of the pig cauda equina. Spine. 1991;16(5):487–493. doi: 10.1097/00007632-199105000-00001.
    1. Takahashi N, Yabuki S, Aoki Y, Kikuchi S. Pathomechanisms of nerve root injury caused by disc herniation: an experimental study of mechanical compression and chemical irritation. Spine. 2003;28(5):435–441.
    1. Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015;372(13):1240–1248. doi: 10.1056/NEJMra1410151.
    1. Heliövaara M, Knekt P, Aromaa A. Incidence and risk factors of herniated lumbar intervertebral disc or sciatica leading to hospitalization. J Chronic Dis. 1987;40(3):251–258. doi: 10.1016/0021-9681(87)90161-5.
    1. Younes M, Béjia I, Aguir Z, Letaief M, Hassen-Zrour S, Touzi M, et al. Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia. Joint Bone Spine. 2006;73(5):538–542. doi: 10.1016/j.jbspin.2005.10.022.
    1. Weber H. Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine. 1983;8(2):131–140. doi: 10.1097/00007632-198303000-00003.
    1. Atlas SJ, Keller RB, Wu YA, Deyo RA, Singer DE. Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine. 2005;30(8):927–935. doi: 10.1097/01.brs.0000158954.68522.2a.
    1. Grovle L, Haugen AJ, Keller A, Ntvig B, Brox JI, Grotle M. Prognostic factors for return to work in patients with sciatica. Spine J. 2013;13(12):1849–1857. doi: 10.1016/j.spinee.2013.07.433.
    1. Pinto RZ, Maher CG, Ferreira ML, Ferreira PH, Hancock M, Oliveira VC, et al. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012;344:e497. doi: 10.1136/bmj.e497.
    1. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 2007;130(1-2):66–75. doi: 10.1016/j.pain.2006.10.029.
    1. Yildirim K, Şışecıoğlu M, Karatay S, Erdal A, Levent A, Uğur M, et al. The effectiveness of gabapentin in patients with chronic radiculopathy. Pain Clin. 2003;15(3):213–218. doi: 10.1163/156856903767650718.
    1. Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376(12):1111–1120. doi: 10.1056/NEJMoa1614292.
    1. Finckh A, Zufferey P, Schurch M-A, Balagué F, Waldburger M, So AK. Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial. Spine. 2006;31(4):377–381. doi: 10.1097/01.brs.0000199917.04145.80.
    1. Holve RL, Barkan H. Oral steroids in initial treatment of acute sciatica. J Am Board Fam Med. 2008;21(5):469–474. doi: 10.3122/jabfm.2008.05.070220.
    1. Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren K-A, Bowman C, et al. The treatment of disc herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine. 2006;31(24):2759–2766. doi: 10.1097/01.brs.0000245873.23876.1e.
    1. Genevay S, Viatte S, Finckh A, Zufferey P, Balagué F, Gabay C. Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62(8):2339–2346. doi: 10.1002/art.27499.
    1. Verheijen E, Bonke C, Amorij E, Vleggeert-Lankamp C. Epidural steroid compared to placebo injection in sciatica: a systematic review and meta-analysis. Eur Spine J. 2021;30(11):3255–3264. doi: 10.1007/s00586-021-06854-9.
    1. Pinto RZ, Maher CG, Ferreira ML, Hancock M, Oliveira VC, McLachlan AJ, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):865–877. doi: 10.7326/0003-4819-157-12-201212180-00564.
    1. Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medication use for low back pain in primary care. Spine. 1998;23(5):607–614. doi: 10.1097/00007632-199803010-00015.
    1. Webster BS, Courtney TK, Huang Y-H, Matz S, Christiani DC. Brief report: physicians’ initial management of acute low back pain versus evidence-based guidelines. J Gen Intern Med. 2005;20(12):1132–1135. doi: 10.1111/j.1525-1497.2005.0230.x.
    1. Piccoliori G, Engl A, Gatterer D, Sessa E, in der Schmitten J, Abholz HH. Management of low back pain in general practice - is it of acceptable quality: an observational study among 25 general practices in South Tyrol (Italy) BMC Fam Pract. 2013;14:148. doi: 10.1186/1471-2296-14-148.
    1. Cummins J, Lurie JD, Tosteson T, Hanscom B, Abdu WA, Birkmeyer NJ, et al. Descriptive epidemiology and prior healthcare utilization of patients in the spine patient outcomes research trial’s (sport) three observational cohorts: disc herniation, spinal stenosis and degenerative spondylolisthesis. Spine. 2006;31(7):806. doi: 10.1097/01.brs.0000207473.09030.0d.
    1. Bronfort G, Hondras MA, Schulz CA, Evans RL, Long CR, Grimm R. Spinal manipulation and home exercise with advice for subacute and chronic back-related leg pain: a trial with adaptive allocation. Ann Intern Med. 2014;161(6):381–391. doi: 10.7326/M14-0006.
    1. Dreiser R-L, Le Parc J, Velicitat P, Lleu P. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac. Inflamm Res. 2001;50(1):17–23. doi: 10.1007/PL00022375.
    1. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009;146(3):238–244. doi: 10.1016/j.pain.2009.08.019.
    1. Weber H, Holme I, Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine. 1993;18(11):1433–1438. doi: 10.1097/00007632-199309010-00006.
    1. Bontoux D. Lombo-radiculalgies: efficacité, tolérance et bénéfice thérapeutique comparés de l’étodolac (600 mg/j), du diclofénac (150 mg/j) et du placebo. Rhumatologie (Aix-les-Bains) 1990;42(7A):201–206.
    1. Herrmann WA, Geertsen MS. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study. Int J Clin Pract. 2009;63(11):1613–1621. doi: 10.1111/j.1742-1241.2009.02187.x.
    1. Rasmussen-Barr E, Held U, Grooten WJ, Roelofs PD, Koes BW, van Tulder MW, et al. Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016;10(10):CD012382.
    1. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 2013;382(9894):769–779. doi: 10.1016/S0140-6736(13)60900-9.
    1. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. doi: 10.1136/bmj.c7086.
    1. Hernández-Díaz S, Rodríguez LAG. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160(14):2093–2099. doi: 10.1001/archinte.160.14.2093.
    1. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1):9–19. doi: 10.1016/j.pain.2004.09.012.
    1. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB. Assessing health-related quality of life in patients with sciatica. Spine. 1995;20(17):1899–1908. doi: 10.1097/00007632-199509000-00011.
    1. Roland M, Morris R. A study of the natural history of back pain: part 1: development of a reliable and sensitive measure of disability in low-back pain. Spine. 1983;8(2):141–144. doi: 10.1097/00007632-198303000-00004.
    1. Grøvle L, Haugen AJ, Keller A, Natvig B, Brox JI, Grotle M. Reliability, validity, and responsiveness of the Norwegian versions of the Maine-Seattle Back Questionnaire and the Sciatica Bothersomeness and Frequency Indices. Spine. 2008;33(21):2347–2353. doi: 10.1097/BRS.0b013e31818047d6.
    1. NorCRIN . Standard operating procedure for safety reporting in clinical drug trials. 2021.
    1. Gotzsche PC. NSAIDs. BMJ Clin Evid. 2010;2010:1108.
    1. Davies NM, Anderson KE. Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997;32(4):268–293. doi: 10.2165/00003088-199732040-00002.
    1. Aminoshariae A, Kulild JC, Donaldson M. Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects: an updated systematic review. J Am Dent Assoc. 2016;147(2):98–110. doi: 10.1016/j.adaj.2015.07.020.
    1. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi: 10.1016/j.jpain.2007.09.005.
    1. Ostenfeld T, Krishen A, Lai RY, Bullman J, Green J, Anand P, et al. A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy. Clin J Pain. 2015;31(4):283–293. doi: 10.1097/AJP.0000000000000122.
    1. Guo Y, Logan HL, Glueck DH, Muller KE. Selecting a sample size for studies with repeated measures. BMC Med Res Methodol. 2013;13(1):1–8. doi: 10.1186/1471-2288-13-100.
    1. Tango T. On the repeated measures designs and sample sizes for randomized controlled trials. Biostatistics. 2016;17(2):334–349. doi: 10.1093/biostatistics/kxv047.
    1. Olsen MF, Bjerre E, Hansen MD, Hilden J, Landler NE, Tendal B, et al. Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Med. 2017;15(1):1–18. doi: 10.1186/s12916-016-0775-3.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅